XML 80 R32.htm IDEA: XBRL DOCUMENT v3.3.1.900
Schedule 1 (Notes)
 12 Months Ended
Dec. 31, 2015
Schedule 1 [Abstract]  
Condensed Financial Information of Parent Company Only Disclosure [Text Block]
Delek US Holdings, Inc.
Parent Company Only
Condensed Balance Sheets
(In millions, except share and per share data)
 
 
December 31,
 
 
2015
 
2014
ASSETS
 
 
 
 
Current assets:
 
 
 
 
Cash and cash equivalents
 
$
138.4

 
$
186.9

Accounts receivable
 
1.6

 
0.9

Interest receivable from subsidiaries
 
7.3

 
2.1

Income tax receivable from subsidiaries
 
—

 
14.0

Other current assets
 
73.9

 
70.9

Total current assets
 
221.2

 
274.8

Property, plant and equipment:
 
 
 
 
Property, plant and equipment
 
35.4

 
28.4

Less: accumulated depreciation
 
(15.3
)
 
(9.6
)
Property, plant and equipment, net
 
20.1

 
18.8

Notes receivable from related parties
 
33.6

 
74.4

Equity method investment
 
564.5

 
—

Investment in subsidiaries
 
798.0

 
865.5

Other non-current assets
 
79.8

 
2.3

Total assets
 
$
1,717.2

 
$
1,235.8

LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
 
Current liabilities:
 
 
 
 
Accounts payable
 
$
7.6

 
$
3.1

Accounts payable to subsidiaries
 
69.0

 
74.6

Income tax payable to subsidiaries
 
5.6

 
—

Current portion of long-term debt and capital lease obligations
 
17.0

 
—

Accrued expenses and other current liabilities
 
49.7

 
24.5

Total current liabilities
 
148.9

 
102.2

Non-current liabilities:
 
 
 
 
Long-term debt and capital lease obligations, net of current portion
 
120.0

 
17.0

Notes payable to subsidiaries
 
242.0

 
102.0

Deferred tax liabilities
 
49.1

 
7.3

Other non-current liabilities
 
4.0

 
5.6

Total non-current liabilities
 
415.1

 
131.9

Shareholders’ equity:
 
 
 
 
Preferred stock, $0.01 par value, 10,000,000 shares authorized, no shares issued and outstanding
 
—

 
—

Common stock, $0.01 par value, 110,000,000 shares authorized, 66,946,721 shares and 60,637,525 shares issued at December 31, 2015 and 2014, respectively
 
0.6

 
0.6

Additional paid-in capital
 
639.2

 
395.1

Accumulated other comprehensive loss
 
(45.3
)
 
(12.6
)
Treasury stock, 4,809,701 and 3,365,561, at cost, as of December 31, 2015 and 2014, respectively.
 
(154.8
)
 
(112.6
)
Retained earnings
 
713.5

 
731.2

Total shareholders’ equity
 
1,153.2

 
1,001.7

Total liabilities and shareholders’ equity
 
$
1,717.2

 
$
1,235.8


The "Notes to Consolidated Financial Statements" of Delek US Holdings, Inc., beginning on page F-11 of this
Form 10-K are an integral part of these condensed financial statements.
Delek US Holdings, Inc.
Parent Company Only
Condensed Statements of Income
(In millions)
 
 
Year Ended December 31,
 
 
2015
 
2014
 
2013
Net sales
 
$
—

 
$
—

 
$
—

Operating costs and expenses:
 
 
 
 
 
 
Cost of goods sold
 
31.6

 
(81.1
)
 
8.8

General and administrative expenses
 
52.6

 
50.9

 
40.8

Depreciation and amortization
 
6.0

 
4.9

 
3.4

Total operating costs and expenses
 
90.2

 
(25.3
)
 
53.0

Operating (loss) income
 
(90.2
)
 
25.3

 
(53.0
)
Interest expense
 
6.0

 
0.6

 
1.8

Interest income
 
(0.7
)
 
(0.2
)
 
—

Net interest expense from related parties
 
7.5

 
1.8

 
2.8

Income from investment in subsidiaries
 
(78.9
)
 
(181.1
)
 
(156.5
)
Income from equity method investment
 
(2.6
)
 
—

 
—

Total non-operating income, net
 
(68.7
)
 
(178.9
)
 
(151.9
)
Income before income taxes
 
(21.5
)
 
204.2

 
98.9

Income tax (benefit) expense
 
(40.9
)
 
5.6

 
(18.8
)
Net income
 
$
19.4

 
$
198.6

 
$
117.7




The "Notes to Consolidated Financial Statements" of Delek US Holdings, Inc., beginning on page F-11 of this
Form 10-K are an integral part of these condensed financial statements.

Delek US Holdings, Inc.
Parent Company Only
Condensed Consolidated Statements of Comprehensive Income
(In millions)

 
 
Year Ended December 31,
 
 
2015
 
2014
 
2013
Net income attributable to Delek
 
$
19.4

 
$
198.6

 
$
117.7

Other comprehensive (loss) income:
 
 
 
 
 
 
Commodity contracts designated as cash flow hedges:
 
 
 
 
 
 
Unrealized (losses) gains, net of ineffectiveness losses (gains) of $21.5 million, $6.3 million, and $(2.5) million for the years ended December 31, 2015, 2014 and 2013, respectively.
 
(41.4
)
 
10.3

 
(6.6
)
Realized gains reclassified to cost of goods sold
 
(0.7
)
 
(22.6
)
 
(0.7
)
Loss on cash flow hedges, net
 
(42.1
)
 
(12.3
)
 
(7.3
)
Income tax benefit
 
14.7

 
4.0

 
2.9

Net comprehensive loss on commodity contracts designated as cash flow hedges
 
(27.4
)
 
(8.3
)
 
(4.4
)
Foreign currency translation loss
 
(0.3
)
 
(0.3
)
 
—

Other comprehensive loss from equity method investments, net of tax benefit of $2.7 million for the year ended December 31, 2015
 
(5.0
)
 
—

 
—

Total other comprehensive loss
 
(32.7
)
 
(8.6
)
 
(4.4
)
Comprehensive income
 
$
(13.3
)
 
$
190.0

 
$
113.3



The "Notes to Consolidated Financial Statements" of Delek US Holdings, Inc., beginning on page F-11 of this
Form 10-K are an integral part of these condensed financial statements.

Delek US Holdings, Inc.
Parent Company Only
Condensed Statements of Cash Flows
(In millions)
 
 
Year Ended December 31,
 
 
2015
 
2014
 
2013
Cash flows from operating activities:
 
 
 
 
 
 
Net income
 
$
19.4

 
$
198.6

 
$
117.7

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 
 
 
Depreciation and amortization
 
6.0

 
4.9

 
3.4

Amortization of deferred financing costs
 
0.1

 
0.4

 
0.4

Deferred income taxes
 
69.0

 
12.8

 
12.1

Equity-based compensation expense
 
11.5

 
7.3

 
6.5

Income tax benefit of equity-based compensation
 
(0.8
)
 
(0.8
)
 
(4.7
)
Income from subsidiaries
 
(78.9
)
 
(181.1
)
 
(156.5
)
Income from equity method investment
 
(2.6
)
 
—

 
—

Dividends from equity method investment
 
15.1

 
—

 
—

Changes in assets and liabilities, net of acquisitions:
 
 
 
 
 
 
Accounts receivable
 
(0.7
)
 
(0.1
)
 
(0.8
)
Inventories and other current assets
 
(8.8
)
 
5.6

 
(24.2
)
Market value of derivatives
 
33.7

 
(47.7
)
 
(5.3
)
Receivables and payables from related parties
 
(5.2
)
 
6.5

 
(8.6
)
Accounts payable and other current liabilities
 
22.8

 
6.1

 
(4.9
)
Non-current assets and liabilities, net
 
(89.2
)
 
7.8

 
(6.4
)
Net cash (used in) provided by operating activities
 
(8.6
)
 
20.3

 
(71.3
)
Cash flows from investing activities:
 
 
 
 
 
 
Business combinations
 
—

 
—

 
(5.1
)
Purchase of non-controlling interest in equity method investment
 
(203.4
)
 
—

 
—

Purchase of property, plant and equipment
 
(6.0
)
 
(5.0
)
 
(9.8
)
Investment in subsidiaries
 
(6.1
)
 
(24.3
)
 
(46.4
)
Dividends from subsidiaries
 
102.4

 
155.3

 
317.2

Net repayments of notes receivable from subsidiaries
 
40.8

 
(1.7
)
 
(27.7
)
Net cash (used in) provided by investing activities
 
(72.3
)
 
124.3

 
228.2

Cash flows from financing activities:
 
 
 
 
 
 
Proceeds from long-term revolver
 
—

 
57.0

 
12.0

Payments on long-term revolver
 
—

 
(50.0
)
 
(6.0
)
Repayment of note payable to related party
 
—

 
(11.8
)
 
—

Proceeds from notes payable to subsidiaries
 
155.0

 
—

 
—

Repayment of note payable to subsidiaries
 
(15.0
)
 
—

 
(23.1
)
Repayments of other debt instruments
 
(25.0
)
 
—

 
(29.1
)
Proceeds from exercise of stock options
 
0.2

 
1.1

 
7.4

Taxes paid due to the net settlement of equity-based compensation
 
(4.3
)
 
(5.2
)
 
(5.0
)
Income tax benefit of equity-based compensation
 
0.8

 
0.8

 
4.7

Repurchase of common stock
 
(42.2
)
 
(74.7
)
 
(37.9
)
Dividends paid
 
(37.1
)
 
(59.2
)
 
(57.3
)
Net cash provided by (used in) financing activities
 
32.4

 
(142.0
)
 
(134.3
)
Net (decrease) increase in cash and cash equivalents
 
(48.5
)
 
2.6

 
22.6

Cash and cash equivalents at the beginning of the period
 
186.9

 
184.3

 
161.7

Cash and cash equivalents at the end of the period
 
$
138.4

 
$
186.9

 
$
184.3

 
 
 
 
 
 
 
Non-cash investing activity:
 
 
 
 
 
 
Equity method investment
 
$
5.0

 
$
—

 
$
—

Increase (decrease) in accrued capital expenditures
 
$
1.3

 
$
(0.1
)
 
$
(1.8
)
 
 
 
 
 
 
 
Non-cash financing activities:
 
 
 
 
 
 
Stock issued in connection with the Alon Acquisition
 
$
230.7

 
$
—

 
$
—

Note payable issued in connection with the Alon Acquisition
 
$
145.0

 
$
—

 
$
—



The "Notes to Consolidated Financial Statements" of Delek US Holdings, Inc., beginning on page F-11 of this
Form 10-K are an integral part of these condensed financial statements.